In vitro and in vivo intrapulmonary distribution of fluorescently labeled surfactant

Critical Care Medicine

Volumn 30, Issue 5, 2002, Pages 1083-1090

  Diemel, Robert V ^a   Walch, Monika ^a   Haagsman, Henk P ^a   Putz, Günther ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Acute respiratory distress syndrome; Alveolar distribution; Fluorescence; Spreading; Surfactant protein B; Surfactant replacement therapy

Indexed keywords

LIPOPOLYSACCHARIDE; LUNG SURFACTANT; SURFACTANT PROTEIN B;

ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY PRESSURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; ATELECTASIS; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS; LUNG ALVEOLUS SURFACE TENSION; LUNG INJURY; MALE; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RAT; TRACHEOTOMY;

EID: 0036250824     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200205000-00020     Document Type: Article

References (47)

1. The pulmonary surfactant system: Biochemical and clinical aspects
2. Pulmonary surfactant: Functions and molecular composition
3. Use of knockout mice to study surfactant protein structure and function
4. Activity of pulmonary surfactant after blocking the associated proteins SP-A and SP-B
5. Pulmonary surfactant therapy
6. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome
7. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome
8. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol
9. The acute respiratory distress syndrome
10. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome
11. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome
12. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis
13. Bovine surfactant therapy for patients with acute respiratory distress syndrome
14. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome
15. Protein composition and surface activity of commercial surfactant preparations
16. Factors influencing efficacy of exogenous surfactant in acute lung injury
17. Aerosolized versus instilled exogenous surfactant in a nonuniform pattern of lung injury
18. Distribution of exogenous surfactant in rabbits with severe respiratory failure: The effect of volume
19. Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique
20. Distribution of endotracheally instilled surfactant protein SP-C in lung-lavaged rabbits
21. Rapid tracheal infusion of surfactant versus bolus instillation in rabbits: Effects on oxygenation, blood pressure and surfactant distribution
22. Intratracheal aerosolization of endotoxin (LPS) in the rat: A comprehensive animal model to study adult (acute) respiratory distress syndrome
23. Evaluation of pressure-driven captive bubble surfactometer
24. Characterization of lipid insertion into monomolecular layers mediated by lung surfactant proteins SP-B and SP-C
25. Fluorometric assay of proteins in the nanogram range
26. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots
27. Functional tests for the characterization of surfactant protein B (SP-B) and a fluorescent SP-B analog
28. A spreading technique for forming film in a captive bubble
29. Improved separation of phospholipids in thin layer chromatography
30. Phosphorus assay in column chromatography
31. Protein permeability in the adult respiratory distress syndrome. Loss of size selectivity of the alveolar epithelium
32. Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome
33. Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome
34. An expanded definition of the adult respiratory distress syndrome
35. Efficacy of Curosurf in a rat model of acute respiratory distress syndrome
36. Alterations of pulmonary surfactant in ARDS - Effects of a transbronchial surfactant application
37. First clinical and early clinical experience with a recombinant SP-C based surfactant
38. Clearance of surfactant protein B from rabbit lungs
39. Surfactant metabolism in surfactant protein A-deficient mice
40. Influence of high frequency ventilation at different end-expiratory lung volumes on the development of lung damage during lung lavage in rabbits
41. Open up the lung and keep the lung open
42. At surfactant deficiency, application of "the open lung concept" prevents protein leakage and attenuates changes in lung mechanics
43. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome
44. Mechanisms of ventilator-induced lung injury: A perspective
45. Advances in mechanical ventilation
46. Meta-analyses of surfactant replacement therapy of infants with birth weights less than 2000 grams
47. Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia